Closing Bell: Nervgen Pharma Corp up on Wednesday (NGEN)

In market activity today, Nervgen Pharma Corp shares opened at $2.89 and closed at $2.88. prices ranged from $2.83 to $2.90.

Share prices advanced 2.86 percent from the previous day's close of $2.80.

During the day across North America, the TSX Composite closed 1.25% at 23110.81, the S&P 500 closed -0.50% at 5436.44, the Dow Jones Industrial Average closed 0.50% at 40743.33 and the Nasdaq Composite closed -1.28% at 17147.42.

Nervgen Pharma Corp traded under NGEN on the Toronto Venture Exchange (TSX-V).

Trading volume was 26,436 on 98 total trades. On average, Nervgen Pharma Corp has traded 30,329 shares over 5 days and 86,208 year-to-date.

The TSX-V overall saw 3,418 price advancers against 1,773 declines and 138 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, in the last 12 months, Nervgen Pharma Corp's shares have soared 77.78%, while in 2024, they have advanced 6.67%.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $195.80 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Currently, Nervgen Pharma Corp's consensus rating is "Strong Sell" based on 0 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..